MoonLake Immunotherapeutics (MLTX) via Helix Acquisition (HLXA) deck

MoonLake Immunotherapeutics AG is a clinical-stage biotechnology company, focused on creating next-level therapies for inflammatory skin and joint diseases.

Debarshi Ghosh

This post is for subscribers only

Subscribe

Already have an account? Log in